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The hormones of the hypothalamic-pituitary-end organ axes play well-established and important roles in the regulation of a variety of physiological functions, including immunological functions and inflammatory reactions [1, 2] . Growth hormone (GH), prolactin (PRL), thyroid-stimulating hormone, and gonadotropins have stimulatory effects on the immune system [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] , whereas gonadal steroids tend to suppress immune function [13] [14] [15] [16] [17] . Physiological levels of adrenocorticotropinstimulated glucocorticoids aid in the development and function of thymocytes, whereas elevated levels suppress granulocyte function and cell-mediated immunity [18] [19] [20] [21] .
Patients with multiple deficiencies of pituitary hormones (known as "panhypopituitarism," or "PHP") are known to have a significantly reduced life expectancy [22] . The increase in mortality is generally attributed to cardiovascular and cerebrovascular disease [22, 23] . Given the complex and potentially important immunomodulatory functions of hormones of the pituitary-end organ axes, we hypothesized that some of this excess mortality could be the result of infectious diseases arising from a breakdown of normal host defenses. As a first step toward addressing this question, we performed a retrospective, case-controlled study of a large population of patients with PHP at the Ben Taub General Hospital in Houston.
PHP was defined as the coexistence of у2 chronic pituitary hormone deficiencies, together with pathological evidence of pituitary or hypothalamic disease. A serious infection was defined as clinical evidence of infection requiring hospitalization plus a positive microbiological culture result or radiographic evidence of infection (e.g., serial chest radiographs showing pneumonic infiltrates with resolution after antibiotic therapy). For the neurosurgical case-control cohort, infections in the perioperative or immediate postoperative periods (within 6 weeks of surgery) were excluded.
The Harris County Hospital District (Harris County, Texas) maintains a computerized database of ∼300,000 patients. We searched this database for patients with multiple pituitary hormone deficiencies diagnosed (International Classification of Diseases [ICD-9] codes 253.2 and 253.7) from 1985 through 1998 [24] . Eighty patients were identified on the basis of 1 of these diagnostic codes. The complete hospital charts of all 80 patients were reviewed. Sixty-five patients fulfilled the criteria for PHP. Among patients who had undergone neurosurgery, PHP was first documented in all but 1 patients within 4-6 weeks after surgery. One patient who had PHP for 30 years had undergone a second neurosurgical procedure for pituitary tumor recurrence.
Twenty-six patients with PHP had undergone partial or complete surgical resections of pituitary lesions during the time period from 1985 through 1998. These 26 patients were compared with 26 control patients who were matched with the patients with PHP for sex and age ‫01ע(‬ years) and who had undergone neurosurgery that did not involve the pituitary gland or hypothalamus. Control patients were identified through a search of the computerized records of the Ben Taub Neurosurgical Unit, which date back to 1985. Each control patient had undergone a neurosurgical procedure within 12 months of the date of pituitary surgery performed on the patient with whom he or she was matched. None of the patients had any debilitating conditions before undergoing their neurosurgical procedure, with the exception of 1 patient with PHP and neurosarcoidosis who had paraplegia. Of the remaining 39 patients with PHP, 21 had received neurosurgical treatment before 1985; therefore, no matched control patients could be identified. Eighteen of the 39 had been treated entirely medically. These 39 patients are hereafter collectively referred to as the "unmatched PHP group."
The complete inpatient and outpatient charts of these 52 patients (26 surgically treated patients with PHP and 26 matched nonpituitary neurosurgically treated control patients) and 39 unmatched patients with PHP were reviewed carefully for the occurrence of significant infections. Table 1 shows the clinical characteristics of the study subjects. Operative approaches to the treatment of sellar lesions in the surgically treated patients with PHP included craniotomy in 10 patients and transsphenoidal resection in 16 patients. All of the neurosurgically treated control patients underwent procedures involving craniotomy with penetration of the dura mater. Fourteen of the neurosurgically treated control patients had malignancies, which are listed in table 1. Two of the control patients had diabetes mellitus, compared with 5 of the surgically treated matched patients with PHP, including 2 of 7 who had serious infections. For matched patients with PHP, the mean duration of hospital stay after surgery was 19.8 days; however, when we excluded 1 patient who stayed in the hospital for 45 days after surgery because of postoperative complications, the mean duration decreased to 13.5 days. This compared with a mean duration of stay of 13.9 days for the neurosurgically treated matched control patients.
Thirteen of 65 patients with PHP experienced a serious infection. In the case-control cohort, 7 of 26 patients with PHP developed serious infections after the perioperative period, whereas only 1 of 26 control patients developed serious infections ( by use of McNemar's test for paired, matched results). P p .04 One of the matched patients with PHP had 2 episodes of serious infection. Six of the 39 unmatched patients with PHP also experienced serious infections. The specific infections are noted in table 2. Five of 7 infections in the matched cohort PHP and 3 of 6 in the group of unmatched patients with PHP were caused by gram-negative bacilli or Staphylococcus aureus, organisms against which granulocytes are the primary host defense. Bilateral pneumonia was diagnosed in 3 of the matched patients with PHP and in 1 of the unmatched patients with PHP. No specific pathogen was identified in any of these cases. Two patients with PHP (1 matched and 1 unmatched) were given a diagnosis of tuberculosis, which suggested depressed cellular immune function. However, both infections occurred in patients who had an increased risk of tuberculosis (1 was 165 years old, and 1 had diabetes mellitus). The only serious infectious episode in the matched control group occurred in a 50-year-old woman with adenocarcinoma of the lung who developed pneumonia 6 months after resection of a metastatic brain lesion.
Diabetes mellitus was the only comorbid condition known to predispose to infections in any of the patients with PHP. Two of 7 matched patients with PHP who had infection also had diabetes mellitus. None of the patients had been treated with immunosuppressive agents, and none had malignancy, renal failure, or AIDS. One patient with neurosarcoidosis had paraplegia and decubitus ulcers that became infected 13 months after neurosurgery and the onset of PHP, which led to sepsis and death (patient 3; table 2).
Because supraphysiological doses of glucocorticoids are associated with a higher risk of infection, we analyzed the glucocorticoid dosing schedules in all the patients. All but 1 of the patients with PHP received commonly accepted replacement doses of glucocorticoids (the equivalent of 0.3-0.5 mg of hydrocortisone per kg, per day, given in 2 divided doses). One patient with PHP who had supratentorial meningioma received a brief course of a higher dose of glucocorticoid (1 mg of dexamethasone t.i.d.) to treat cerebral edema immediately after the surgery. For periods ranging from 2 to 5 days after admission to the hospital, all the patients with PHP received "stress" doses of steroids (50-100 mg hydrocortisone every 6-8 h) for the treatment of serious infections. Fourteen of 26 control patients had malignant disease and were treated with multiple chemotherapeutic agents. These subjects could have been immunosuppressed for varying periods.
All patients with PHP were evaluated by use of standard tests of pituitary function. In the matched neurosurgically treated patients with PHP, these tests were performed within 2 months after the surgical procedure to diagnose hormone deficiencies and to initiate replacement therapy (as listed in table 2). In a few cases, hormone values immediately after surgery were available. After neurosurgical treatment, 2 patients with Cushing's disease had no evidence of cortisol excess, and 2 patients with acromegaly had no evidence of GH excess. Three patients with prolactinoma continued to have higher than normal plasma levels of PRL immediately after surgery.
Four of the matched patients with PHP and 1 of the unmatched patients with PHP died of a serious infection, compared with 3 of the neurosurgically treated control patients. Two of the 3 deaths in the control group were the result of noninfectious causes. The infections leading to death in patients with PHP included bilateral pneumonia in 2 patients and softtissue infections and associated sepsis in 2. Two of the patients with PHP who died also had diabetes mellitus. One of the control patients died of postoperative bacterial meningitis and sepsis, and the other 2 died of spread of metastatic malignant disease.
Nine of the matched patients with PHP and 7 patients in the control group had received radiation therapy to the pituitary gland and the brain, respectively. One patient with PHP in this group developed bilateral pneumonia, and another had soft-tissue infection with S. aureus. The control patient who developed pneumonia had received brain irradiation. Pituitary function in the control patients who had received brain irradiation was not evaluated; however, there was no clinical evidence that these patients had pituitary dysfunction.
In this study, we documented a high frequency of serious infections in patients with PHP. This frequency was significantly higher among the matched surgically treated patients than among control patients matched for age, sex, and time of surgery, despite the fact that many of the control patients (but none of the matched patients with PHP) had malignancies.
Six episodes of pneumonia were documented in 5 patients with PHP. Bilateral pneumonia was noted in 3 patients with PHP in the matched cohort and in 2 unmatched patients with PHP. Community-acquired pneumonia is a common infection in the general population. The high frequency of communityacquired pneumonia that required hospitalization in the patients with PHP in this series may merely reflect the a blunted stress response in patients with a defective hypothalamic-pituitary-adrenal axis. Patients might therefore have developed manifestations of this common infection. Alternatively, this could also point to intrinsic defects in host defenses or chronic glucocorticoid overtreatment. Host defenses against pneumonia are complex and redundant [25, 26] . Recurrent respiratory infections are frequently noted in patients with defects in their humoral immune response (antibody and complement) [27] . These cases are typically associated with encapsulated organisms, such as Pneumococcus species. Pneumococcus species were not identified in any of the patients we studied, but retrospective series often fail to identify the microbial cause in patients with pneumonia [28] .
Granulocyte function is also a key component of pulmonary host defenses. Glucocorticoids inhibit neutrophil accumulation and plasma exudation at sites of inflammation [29] . Most of the infections that we found involved gram-negative bacilli or S. aureus. Patients with granulocytopenia or granulocyte dysfunction are known to be particularly susceptible to microbial infections [27] . The fact that all the serious infections in the patients with PHP in our study were due to bacteria raises the possibility of granulocyte dysfunction in patients with PHP. Two of the patients with PHP who acquired serious infections also had diabetes mellitus, which is associated with blunted granulocyte function.
Inadvertent treatment of patients with PHP with the use of supraphysiological doses of glucocorticoids could also have aggravated granulocyte dysfunction. A review of infectious complications in patients with Cushing's syndrome showed a higher risk of bacterial infections, especially in patients with ectopic adrenocorticotropin syndrome [29] . The RR of infection in patients receiving glucocorticoid treatment for nonmalignant diseases was 1.5 times that of control patients, according to a meta-analysis of 71 trials [29] . However, doses of р10 mg of prednisone per day pose little risk of infection [29] . The effect of glucocorticoid on cell-mediated immunity is less profound [29] . In this series, the only other patients with an infection associated with depressed cellular immunity were 2 patients with PHP who also had tuberculosis: one had pulmonary tuberculosis together with diabetes mellitus, and the other was an elderly patient with tuberculous lymphadenitis.
In the cohort we studied, all the patients with PHP who required glucocorticoid replacement appeared to have been prescribed the standard dose, although our retrospective design is not ideal for detecting subtle problems with medication dosages or patient compliance. All the patients with PHP received adequate thyroid hormone replacement; therefore thyroid hormone deficiency is unlikely to have played a role in increasing the frequency of infections.
Interactions between GH, PRL, and the immune system have been demonstrated in vitro and in animal models [1, 3, 10] . None of the patients with PHP who had infections had documented GH deficiency. It is possible that these patients were GH deficient and that they had associated immune dysfunction that could have contributed to their susceptibility to infection. PRL levels were high in 2 patients with PHP who had infections: one had staphylococcal soft-tissue infection, and the other had pneumonia with no identified microorganism. PRL levels were not measured at the time of hospital admission for the rest of the patients with PHP. The role of PRL deficiency or excess in the remainder of the patients with PHP who had infections is uncertain.
Estrogen enhances systemic antibody production and exacerbates certain autoimmune diseases [13] . Estrogens and testosterone may also depress cell-mediated immunity [13, 16, 17] . Progesterone inhibits the function of phagocytes and decreases host resistance to viral and fungal infections (e.g., coccidioidomycosis and candidiasis) [1] . In our study, a large number of patients with PHP appeared to have a deficiency of sex steroids. Five of 7 women and 2 of 6 men with PHP who developed infections were receiving sex steroid replacement. Because the effects of sex steroids on the immune system are variable, the precise association of sex steroid deficiency or excessive replacement therapy with predisposition to infection needs to be better defined.
We have shown that there is a high frequency of serious infections in patients with multiple pituitary hormone deficiencies. This predisposition to infection, particularly those infections caused by bacterial pathogens, may contribute significantly to the increased mortality reported in these patients. Patients with PHP may be susceptible to these infections as a result of immune defects arising from GH deficiency, PRL deficiency or excess, and sex steroid deficiency or overzealous glucocorticoid replacement therapy. These findings should stimulate further investigation into the role of these hormones in immune function. They also have important implications regarding rational guidelines for hormone replacement regimens as well as for antibacterial prophylaxis in patients with PHP.
